Position in GH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$509,098,599
+$200,745,278 QoQ
Shares Held
3,393,312
+1.6% QoQ
Ownership
2.53%
of shares outstanding
% of Portfolio
7.75%
of 13F equity value
Holder Rank
#10
of 594 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Deep Track Capital, LP holds $736,025,225 across 4 Diagnostics & Research names. GH ranks #1 (69.2% of the industry book) .
All Filings in GH
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $509,098,599 | 3,393,312 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $308,353,321 | 3,338,241 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $285,992,000 | 2,800,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $259,547,293 | 4,154,086 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $221,170,000 | 4,250,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $231,902,514 | 5,443,721 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $196,117,741 | 6,419,566 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $137,652,846 | 6,000,560 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $129,960,000 | 4,500,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $123,780,000 | 6,000,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $135,250,000 | 5,000,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $120,042,000 | 4,050,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $53,700,000 | 1,500,000 | Shares | Sole | 2023-09-06 | |
| No filing history on record for this holder in this stock. | ||||||